10/05/2015 | Sponsored by Santen Pharmaceuticals
Preserved glaucoma product use increases the probability that future glaucoma surgery will fail. Let’s examine the literature…
09/14/2015
For doctors and other operators to get familiar with the Widefield Imaging Module, the Heidelberg Engineering Academy has recently launched an interactive video tutorial.
08/11/2015 | Sponsored by Santen Pharmaceuticals
Taking the time to talk with patients about the signs and symptoms of ocular surface disease and performing some quick assessments could ensure selection of the most appropriate therapy, and help improve patient outcomes
08/11/2015 | Roisin McGuigan
“Smart” nanowires deliver drugs on demand using an applied electromagnetic field
06/09/2015 | Sponsored by Santen Pharmaceuticals
Why persist with preservatives? Those present in topical glaucoma therapies don’t improve the active compound’s efficacy – and cause ocular surface disease in many patients
06/08/2015 | Michael Schubert
A light box and a 35 mm slide could be all you need for therapeutic laser target practice
05/11/2015
Thermography could offer a noninvasive way of assessing bleb function
VR headsets could identify those with glaucoma at the greatest risk of falls
05/11/2015 | Sponsored by Santen Pharmaceuticals
As many as six in every ten patients with glaucoma have ocular surface disease – and this can have a huge impact on their daily lives. We explore why, and what can be done.
01/12/2015 | Steven Vold
Trimming down the number of concomitant topical glaucoma medications your patients need with MIGS devices could lead to happier patients with better-controlled IOP.
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Redressing Representation
Living with TED: My Race from Patient to Advocate
How Dry Eye Disease Impacts Younger Patients
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: